2025
SJR Q1
JCR Q1 · 5
15 eşleşen makale
SCIE
Dergi ayrıntısı
Journal of Molecular Medicine
- Yayıncı
- Springer Science and Business Media Deutschland GmbH
- Ülke
- Germany · Western Europe
- Tür
- journal
- ISSN
-
0946271614321440
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 1,401
- Quartile Q1
- H-Index 167
- Atıf/yayın 4,85
- Doküman (3y) 345
- Atıf (3y) 1.702
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 5
- 5Y JIF 5,3
- JCI 0,89
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
- Drug Discovery Q1
- Genetics (clinical) Q1
- Molecular Medicine Q1
Alanlar
- Biochemistry, Genetics and Molecular Biology
- Medicine
- Pharmacology, Toxicology and Pharmaceutics
WoS kategorileri
- Genetics & Heredity | Medicine, Research & Experimental
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 1,401 | 5 | 5,3 | 0,89 | Q2 | 167 |
| 2024 | Q1 | Q1 | 1,473 | 4,2 | 4,7 | 0,9 | Q2 | 162 |
| 2023 | Q1 | Q1 | 1,422 | 4,8 | 4,7 | 0,93 | Q2 | 162 |
| 2022 | Q1 | Q1 | 1,276 | 4,7 | 5,1 | 0,94 | Q2 | 162 |
| 2021 | Q1 | Q1 | 1,306 | 5,6 | 6,4 | 1 | Q1 | 162 |
| 2020 | Q1 | Q2 | 1,708 | 4,6 | 6 | 1,12 | Q1 | 162 |
| 2019 | Q1 | Q1 | 2,003 | 4,4 | 5 | 1,28 | Q1 | 162 |
| 2018 | — | Q1 | — | 4,7 | 5,1 | 1,28 | Q1 | — |
| 2017 | Q1 | Q1 | 2,177 | 4,9 | 5,1 | 1,4 | Q1 | 162 |
| 2016 | Q1 | Q1 | 2,207 | 4,7 | 5 | — | — | 162 |
| 2015 | Q1 | Q1 | 2,251 | 4,9 | 4,4 | — | — | 162 |
| 2014 | Q1 | Q1 | 2,52 | 5,1 | 4,7 | — | — | 162 |
| 2013 | Q1 | Q1 | 2,44 | 4,7 | 4,6 | — | — | 162 |
| 2012 | Q1 | Q1 | 2,401 | 4,8 | 5 | — | — | 162 |
| 2011 | Q1 | Q1 | 2,513 | 4,7 | 4,7 | — | — | 162 |
| 2010 | Q1 | Q1 | 2,611 | 5,2 | 5,2 | — | — | 162 |
| 2009 | — | Q1 | — | 5 | 5 | — | — | — |
| 2008 | — | Q1 | — | 4,4 | 4,9 | — | — | — |
| 2007 | — | Q1 | — | 4,8 | 4,9 | — | — | — |
| 2006 | — | Q1 | — | 5,2 | — | — | — | — |
| 2005 | — | Q1 | — | 4,7 | — | — | — | — |
| 2004 | — | Q1 | — | 4,3 | — | — | — | — |
| 2003 | — | Q1 | — | 4,1 | — | — | — | — |
| 2002 | — | Q1 | — | 3,3 | — | — | — | — |
| 2001 | — | Q1 | — | 3,5 | — | — | — | — |
| 2000 | — | Q1 | — | 3,4 | — | — | — | — |
| 1999 | — | Q1 | — | 3,7 | — | — | — | — |
| 1998 | — | Q1 | — | 3,7 | — | — | — | — |
| 1997 | — | Q1 | — | 2,8 | — | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | GENETICS & HEREDITY | SCIE | Q1 | Q2 | 36/192 |
| 2025 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q2 | 49/191 |
| 2024 | GENETICS & HEREDITY | SCIE | Q1 | Q2 | 41/192 |
| 2024 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q2 | 56/195 |
| 2023 | GENETICS & HEREDITY | SCIE | Q1 | Q2 | 29/191 |
| 2023 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | Q2 | 45/189 |
| 2022 | GENETICS & HEREDITY | SCIE | Q1 | Q2 | 34/171 |
| 2022 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q2 | 54/136 |
| 2021 | GENETICS & HEREDITY | SCIE | Q1 | Q1 | 32/175 |
| 2021 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q2 | 47/139 |
| 2020 | GENETICS & HEREDITY | SCIE | Q2 | Q1 | 48/176 |
| 2020 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q1 | 58/140 |
| 2019 | GENETICS & HEREDITY | SCIE | Q1 | Q1 | 38/178 |
| 2019 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q1 | 37/139 |
| 2018 | GENETICS & HEREDITY | SCIE | Q1 | Q1 | 29/174 |
| 2018 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | Q1 | 26/136 |
| 2017 | GENETICS & HEREDITY | SCIE | Q1 | Q1 | 29/171 |
| 2017 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | Q1 | 20/133 |
| 2016 | GENETICS & HEREDITY | SCIE | Q1 | — | 27/167 |
| 2016 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 18/128 |
| 2015 | GENETICS & HEREDITY | SCIE | Q1 | — | 27/166 |
| 2015 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 19/124 |
| 2014 | GENETICS & HEREDITY | SCIE | Q1 | — | 27/167 |
| 2014 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 16/123 |
| 2013 | GENETICS & HEREDITY | SCIE | Q1 | — | 31/165 |
| 2013 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 17/124 |
| 2012 | GENETICS & HEREDITY | SCIE | Q1 | — | 26/161 |
| 2012 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 18/121 |
| 2011 | GENETICS & HEREDITY | SCIE | Q1 | — | 25/158 |
| 2011 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 15/112 |
| 2010 | GENETICS & HEREDITY | SCIE | Q1 | — | 22/156 |
| 2010 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 13/106 |
| 2009 | GENETICS & HEREDITY | SCIE | Q1 | — | 21/146 |
| 2009 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 14/93 |
| 2008 | GENETICS & HEREDITY | SCIE | Q1 | — | 26/138 |
| 2008 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 11/83 |
| 2007 | GENETICS & HEREDITY | SCIE | Q1 | — | 21/132 |
| 2007 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 9/81 |
| 2006 | GENETICS & HEREDITY | SCIE | Q1 | — | 23/131 |
| 2006 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 7/76 |
| 2005 | GENETICS & HEREDITY | SCIE | Q1 | — | 22/124 |
| 2005 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 9/72 |
| 2004 | GENETICS & HEREDITY | SCIE | Q1 | — | 23/120 |
| 2004 | MEDICAL LABORATORY TECHNOLOGY | SCIE | Q1 | — | 2/24 |
| 2004 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 10/71 |
| 2003 | GENETICS & HEREDITY | SCIE | Q1 | — | 26/120 |
| 2003 | MEDICAL LABORATORY TECHNOLOGY | SCIE | Q1 | — | 3/26 |
| 2003 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 9/72 |
| 2002 | GENETICS & HEREDITY | SCIE | Q2 | — | 35/115 |
| 2002 | MEDICAL LABORATORY TECHNOLOGY | SCIE | Q1 | — | 5/28 |
| 2002 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 13/74 |
| 2001 | GENETICS & HEREDITY | SCIE | Q2 | — | 32/113 |
| 2001 | MEDICAL LABORATORY TECHNOLOGY | SCIE | Q1 | — | 5/24 |
| 2001 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 11/75 |
| 2000 | GENETICS & HEREDITY | SCIE | Q1 | — | 28/114 |
| 2000 | MEDICAL LABORATORY TECHNOLOGY | SCIE | Q1 | — | 3/24 |
| 2000 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 10/74 |
| 1999 | GENETICS & HEREDITY | SCIE | Q1 | — | 21/105 |
| 1999 | MEDICAL LABORATORY TECHNOLOGY | SCIE | Q1 | — | 3/26 |
| 1999 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 10/76 |
| 1998 | GENETICS & HEREDITY | SCIE | Q1 | — | 21/103 |
| 1998 | MEDICAL LABORATORY TECHNOLOGY | SCIE | Q1 | — | 2/26 |
| 1998 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 10/72 |
| 1997 | GENETICS & HEREDITY | SCIE | Q2 | — | 26/90 |
| 1997 | MEDICAL LABORATORY TECHNOLOGY | SCIE | Q1 | — | 4/21 |
| 1997 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 11/61 |